# Artificial Tears, Tear Lipids and Tear Film Dynamics

> **NCT05705518** · PHASE4 · COMPLETED · sponsor: **University of California, Berkeley** · enrollment: 81 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** Systane Complete PF
- **DRUG:** Refresh Relieva PF
- **DRUG:** Refresh Optive Mega-3 PF
- **DRUG:** CVS Health Lubricant Eye Drop (PG 0.6%)

## Key facts

- **NCT ID:** NCT05705518
- **Lead sponsor:** University of California, Berkeley
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-30
- **Primary completion:** 2023-09-30
- **Final completion:** 2024-01-30
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2025-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05705518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05705518, "Artificial Tears, Tear Lipids and Tear Film Dynamics". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05705518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*